| Vildagliptin |
EU/1/07/414/003 |
Galvus, Tablet, 50, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
|
КЦ-912/26.05.2009 |
19.06.2009 |
Неактивен |
2855 |
| Immunoglobuline, normal human for extravascular adm. |
20100812 |
GAMMANORM, Solution for injection, 165 mg/ml - 20 ml, mg, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma AB SE -112 75 Stockholm Sweden |
254.26 |
50.85 |
305.11 |
4% |
10 |
264.26 |
52.85 |
317.11 |
16% |
25 |
289.26 |
57.85 |
347.11 |
|
НСР-1311/03.10.2013 |
21.10.2013 |
Активен |
2158 |
| Immunoglobuline, normal human for extravascular adm. |
20100812 |
GAMMANORM, Solution for injection, 165 mg/ml - 20 ml, mg, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma AB SE -112 75 Stockholm Sweden |
277.57 |
55.51 |
333.08 |
4% |
10 |
287.57 |
57.51 |
345.08 |
16% |
25 |
312.57 |
62.51 |
375.08 |
|
КЦРР-1778/06.12.2012 ; КЦРР-1862/15.12.2012 |
19.12.2012 |
Неактивен |
2158 |
| Immunoglobuline, normal human for extravascular adm. |
20100812 |
GAMMANORM, Solution for injection, 165 mg/ml - 10 ml, mg, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma AB SE -112 75 Stockholm Sweden |
119.31 |
23.86 |
143.17 |
4% |
4.77 |
124.08 |
24.82 |
148.9 |
16% |
19.09 |
143.17 |
28.63 |
171.8 |
|
КЦРР-1778/06.12.2012 ; КЦРР-1862/15.12.2012 ;НСР-146/07.06.2013 |
19.12.2012 |
Активен |
1471 |
| Immunoglobuline, normal human for extravascular adm. |
№ ІІ-11489/08.12.2010 |
GAMMANORM, Solution for injection, 165 mg/ml - 10 ml, mg, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma AB, Stockholm, Швеция |
145.22 |
29.04 |
174.26 |
4% |
5.81 |
151.03 |
30.21 |
181.24 |
16% |
23.24 |
174.27 |
34.85 |
209.12 |
|
КЦ-2489/26.07.2011 |
10.08.2011 |
Неактивен |
1471 |
| Immunoglobuline, normal human for extravascular adm. |
№ ІІ-11489/08.12.2010 |
GAMMANORM, Solution for injection, 165 mg/ml - 20 ml, mg, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma AB, Stockholm, Швеция |
290.44 |
58.09 |
348.53 |
4% |
10 |
300.44 |
60.09 |
360.53 |
16% |
25 |
325.44 |
65.09 |
390.53 |
|
КЦ-2487/26.07.2011 |
10.08.2011 |
Неактивен |
2158 |
| Bimatoprost, Timolol |
EU/1/06/340/001 |
GANFORT, Eye drops, solution, 0.3 mg/ml + 5 mg/ml, mg, Pack: 3 ml x 1 |
Allergan Pharmaceuticals, Ирландия |
Allergan Pharmaceuticals Ireland Castlebar Road Westport Co. Mayo Ирландия |
22.34 |
4.47 |
26.81 |
6% |
1.34 |
23.68 |
4.74 |
28.42 |
18% |
4.02 |
27.7 |
5.54 |
33.24 |
|
НСР-5973/01.04.2015. |
16.04.2015 |
Неактивен |
3725 |
| Bimatoprost, Timolol |
EMEA/H/C/668/001 |
GANFORT, Eye drops, solution, 0.3 mg/ml + 5 mg/ml, mg, Pack: 3 ml x 1 |
Allergan Pharmaceuticals, Ирландия |
Allergan Pharmaceuticals Ireland Castlebar Road Westport Co. Mayo Ирландия |
23.06 |
4.61 |
27.67 |
6% |
1.38 |
24.44 |
4.89 |
29.33 |
18% |
4.15 |
28.59 |
5.72 |
34.31 |
|
НСР-1933/27.11.2013 |
20.02.2014 |
Неактивен |
3725 |
| Bimatoprost, Timolol |
EMEA/H/C/668/001 |
GANFORT, Eye drops, solution, 0.3 mg/ml + 5 mg/ml, mg, Pack: 3 ml x 1 |
Allergan Pharmaceuticals, Ирландия |
Allergan Pharmaceuticals Ireland Castlebar Road Westport Co. Mayo Ирландия |
24.04 |
4.81 |
28.85 |
6% |
1.44 |
25.48 |
5.1 |
30.58 |
18% |
4.33 |
29.81 |
5.96 |
35.77 |
|
КЦРР-2316/20.02.2013 |
12.03.2013 |
Неактивен |
3725 |
| Succinylated Gelatine, Sodium Chloride |
II-0626/18.09.2007 |
Gelofusine 4%, Solution for infusion, 500 ml, -, Pack: 10 bottles Ecoflack plus |
B. Braun Melsungen AG, Германия |
B.Braun Melsungen AG, Carl Braun Str.1, Melsungen Germany |
54.22 |
10.84 |
65.06 |
4% |
2.17 |
56.39 |
11.28 |
67.67 |
16% |
8.68 |
65.07 |
13.01 |
78.08 |
|
КЦ-346/17.12.2008 |
26.01.2009 |
Активен |
335 |
| Timolol |
20100276/ 27.04.2010 |
Geltim, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 |
Laboratoires Thea, Франция |
Laboratoire Unither, France |
7.9 |
1.58 |
9.48 |
7% |
0.55 |
8.45 |
1.69 |
10.14 |
20% |
1.58 |
10.03 |
2.01 |
12.04 |
протокол № 172/04.05.2016 |
НСР-3686/06.06.2014 |
23.06.2014 |
Активен |
2897 |
| Timolol |
20100276/ 27.04.2010 |
Geltim Eye, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 |
Laboratoires Thea, Франция |
Laboratoire Unither, France |
7.9 |
1.58 |
9.48 |
7% |
0.55 |
8.45 |
1.69 |
10.14 |
20% |
1.58 |
10.03 |
2.01 |
12.04 |
|
НСР-3686/06.06.2014 |
23.06.2014 |
Неактивен |
2897 |
| Timolol |
20100276/ 27.04.2010 |
Geltim Eye, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 |
Laboratoires Thea, Франция |
Laboratoire Unither, France |
9.52 |
1.9 |
11.42 |
7% |
0.67 |
10.19 |
2.04 |
12.23 |
20% |
1.9 |
12.09 |
2.42 |
14.51 |
|
НСР-1335/07.10.2013 |
29.10.2013 |
Неактивен |
2897 |
| Timolol |
20100276/ 27.04.2010 |
Geltim Eye, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 |
Laboratoires Thea, Франция |
Laboratoire Unither, France |
10.01 |
2 |
12.01 |
6% |
0.6 |
10.61 |
2.12 |
12.73 |
18% |
1.8 |
12.41 |
2.48 |
14.89 |
|
КЦРР-1757/04.12.2012 г |
17.01.2013 |
Неактивен |
2897 |
| Gemcitabine |
20100752/23.11.2010 |
Gembin, Concentrate for solution for infusion, 40 mg/ml - 25 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A.-Nerviano Plant, Италия |
77.53 |
15.51 |
93.04 |
4% |
3.1 |
80.63 |
16.13 |
96.76 |
16% |
12.4 |
93.03 |
18.61 |
111.64 |
|
КЦРР-2114/28.01.2013 г |
14.02.2013 |
Активен |
1577 |
| Gemcitabine |
20100752/23.11.2010 |
Gembin, Concentrate for solution for infusion, 40 mg/ml - 5 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A.-Nerviano Plant, Италия |
16.72 |
3.34 |
20.06 |
6% |
1 |
17.72 |
3.54 |
21.26 |
18% |
3.01 |
20.73 |
4.15 |
24.88 |
|
КЦРР-2114/28.01.2013 г |
14.02.2013 |
Активен |
1576 |
| Gemcitabine |
20100377/25.01.2011 |
GEMCIT, Powder for solution for infusion, 38 mg/ml 2 000 mg, 100 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesellschaft fur klinische Spezialpraparate mbH, Fehlandtstr. 3, 20354 Hamburg, Германия; Fresenius Kabi Oncology Plc. Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, Обединено кралство |
126.15 |
25.23 |
151.38 |
4% |
5.05 |
131.2 |
26.24 |
157.44 |
16% |
20.18 |
151.38 |
30.28 |
181.66 |
|
НСР-7523/19.11.2015. |
05.12.2015 |
Активен |
1921 |
| Gemcitabine |
20100377/ 15.06.2010 |
GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesllschaft fur klinische Spezialpraparate GmbH, Fehlandstr. 3, 20354 Hamburg, Germany; 2. Fresenius Kabi Oncology Plc., Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, UK |
56.48 |
11.3 |
67.78 |
4% |
2.26 |
58.74 |
11.75 |
70.49 |
16% |
9.04 |
67.78 |
13.56 |
81.34 |
|
НСР-6534/24.06.2015 |
10.07.2015 |
Активен |
2699 |
| Gemcitabine |
20100377 |
GEMCIT, Powder for solution for infusion, 38 mg/ml, 200 mg/vial, 10 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство |
14.45 |
2.89 |
17.34 |
6% |
0.87 |
15.32 |
3.06 |
18.38 |
18% |
2.6 |
17.92 |
3.58 |
21.5 |
|
НСР-3787/16.06.2014 |
01.07.2014 |
Активен |
2943 |
| Gemcitabine |
20100377/ 15.06.2010 |
GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesllschaft fur klinische Spezialpraparate GmbH, Fehlandstr. 3, 20354 Hamburg, Germany; 2. Fresenius Kabi Oncology Plc., Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, UK |
75.67 |
15.13 |
90.8 |
4% |
3.03 |
78.7 |
15.74 |
94.44 |
16% |
12.11 |
90.81 |
18.16 |
108.97 |
|
НСР-3183/07.04.2014 |
23.04.2014 |
Неактивен |
2699 |
| Gemcitabine |
20100377/25.01.2011 |
GEMCIT, Powder for solution for infusion, 38 mg/ml 2 000 mg, 100 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesellschaft fur klinische Spezialpraparate mbH, Fehlandtstr. 3, 20354 Hamburg, Германия; Fresenius Kabi Oncology Plc. Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, Обединено кралство |
155.55 |
31.11 |
186.66 |
4% |
6.22 |
161.77 |
32.35 |
194.12 |
16% |
24.89 |
186.66 |
37.33 |
223.99 |
|
HCР-486/11.07.2013. |
29.07.2013 |
Неактивен |
1921 |
| Gemcitabine |
20100377 |
GEMCIT, Powder for solution for infusion, 38 mg/ml, 200 mg/vial, 10 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство |
16.64 |
3.33 |
19.97 |
6% |
1 |
17.64 |
3.53 |
21.17 |
18% |
3 |
20.64 |
4.13 |
24.77 |
|
КЦРР-2723/20.03.2013 |
19.04.2013 |
Неактивен |
2943 |
| Gemcitabine |
20100377/ 15.06.2010 |
GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesllschaft fur klinische Spezialpraparate GmbH, Fehlandstr. 3, 20354 Hamburg, Germany; 2. Fresenius Kabi Oncology Plc., Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, UK |
75.69 |
15.14 |
90.83 |
4% |
3.03 |
78.72 |
15.74 |
94.46 |
16% |
12.11 |
90.83 |
18.17 |
109 |
|
КЦРР-2112/28.01.2013 г |
12.02.2013 |
Неактивен |
2699 |
| Gemcitabine |
II-9964/ 15.06.2010 |
GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство |
135.44 |
27.09 |
162.53 |
4% |
5.42 |
140.86 |
28.17 |
169.03 |
16% |
21.67 |
162.53 |
32.51 |
195.04 |
|
КЦ-2182/04.05.2011 |
18.05.2011 |
Неактивен |
2699 |
| Gemcitabine |
II-9964/ 15.06.2010 |
GEMCIT, Powder for solution for infusion, 38 mg/ml, 200 mg/vial, 10 ml, mg, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство |
27.09 |
5.42 |
32.51 |
6% |
1.63 |
28.72 |
5.74 |
34.46 |
18% |
4.88 |
33.6 |
6.72 |
40.32 |
издадена корекционна КЦ-2181/04.05.2011 |
КЦ-2182/04.05.2011 |
18.05.2011 |
Неактивен |
2943 |